PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED AND UNINFE

HIV 感染者和 UNINFE 中形态和代谢异常的患病率

基本信息

  • 批准号:
    7717162
  • 负责人:
  • 金额:
    $ 0.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-12-01 至 2008-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a cross-sectional survey designed to evaluate the prevalence and severity of morphologic and metabolic abnormalities in HIV infected female youth, and to assess the drug and non-drug factors related to these abnormalities. This study is designed to assess whether there exist significant differences in glucose metabolism, lipids, lactate, body composition and bone density between HIV infected and uninfected young women. Furthermore, this study will evaluate whether exposure to specific classes of antiretroviral (ARV) medications is associated with metabolic and morphologic abnormalities among HIV infected individuals in different ways. This study will elucidate the need for further in-depth study to understand the pathophysiological effects of protease inhibitor (PI) - and non-nucleoside analogue reverse transcriptase inhibitor (NNRTI) - based therapies in young females.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAWRENCE James D'ANGELO其他文献

LAWRENCE James D'ANGELO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAWRENCE James D'ANGELO', 18)}}的其他基金

ATN 064: IMMUNOGENICITY, SAFETY, TOLERABILITY, AND BEHAVIORAL CONSEQUENCES OF
ATN 064:免疫原性、安全性、耐受性和行为后果
  • 批准号:
    8167298
  • 财政年份:
    2010
  • 资助金额:
    $ 0.81万
  • 项目类别:
ATN 063: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SAFETY A
ATN 063:安全性的随机、双盲、安慰剂对照试验
  • 批准号:
    8167361
  • 财政年份:
    2010
  • 资助金额:
    $ 0.81万
  • 项目类别:
ATN 070: PSYCHOSOCIAL NEEDS OF HIV+ YOUNG MEN WHO HAVE SEX WITH MEN (YMSM), V
ATN 070:男男性行为艾滋病毒青年男性的社会心理需求 (YMSM),V
  • 批准号:
    8167299
  • 财政年份:
    2010
  • 资助金额:
    $ 0.81万
  • 项目类别:
ATN 061: PRESERVATION AND EXPANSION OF T-CELL SUBSETS FOLLOWING HAART DE-INTE
ATN 061:HAART DE-INTE 后 T 细胞亚群的保存和扩增
  • 批准号:
    8167342
  • 财政年份:
    2010
  • 资助金额:
    $ 0.81万
  • 项目类别:
HUMAN IMMUNODEFICIENCY VIRUS(HIV) PREVENTION PROJECTS FOR COMMUNITY BASED ORGS
社区组织的人类免疫缺陷病毒 (HIV) 预防项目
  • 批准号:
    8117731
  • 财政年份:
    2010
  • 资助金额:
    $ 0.81万
  • 项目类别:
HUMAN IMMUNODEFICIENCY VIRUS(HIV) PREVENTION PROJECTS FOR COMMUNITY BASED ORGS
社区组织的人类免疫缺陷病毒 (HIV) 预防项目
  • 批准号:
    7983184
  • 财政年份:
    2010
  • 资助金额:
    $ 0.81万
  • 项目类别:
ATN 024: A RANDOMIZED, OPEN-LABEL TRIAL OF THREE HEPATITIS B VACCINATION
ATN 024:三种乙型肝炎疫苗的随机、开放标签试验
  • 批准号:
    7951093
  • 财政年份:
    2008
  • 资助金额:
    $ 0.81万
  • 项目类别:
ATN 063: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SAFETY A
ATN 063:安全性的随机、双盲、安慰剂对照试验
  • 批准号:
    7951132
  • 财政年份:
    2008
  • 资助金额:
    $ 0.81万
  • 项目类别:
ATN 048: CORRELATES OF HBV-SPECIFIC B CELL MEMORY FOLLOWING VACCINATION IN HIV
ATN 048:HIV 疫苗接种后 HBV 特异性 B 细胞记忆的相关性
  • 批准号:
    7951110
  • 财政年份:
    2008
  • 资助金额:
    $ 0.81万
  • 项目类别:
ATN 061: PRESERVATION AND EXPANSION OF T-CELL SUBSETS FOLLOWING HAART DE-INTE
ATN 061:HAART DE-INTE 后 T 细胞亚群的保存和扩增
  • 批准号:
    7951106
  • 财政年份:
    2008
  • 资助金额:
    $ 0.81万
  • 项目类别:

相似海外基金

Understanding causes and consequences of variation in body composition, cardiorespiratory and muscular fitness
了解身体成分、心肺和肌肉健康变化的原因和后果
  • 批准号:
    MR/Y009398/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.81万
  • 项目类别:
    Fellowship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
  • 批准号:
    10674401
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
Effects of daily low oxygen exposure on weight status, body composition, and metabolic health
每日低氧暴露对体重状况、身体成分和代谢健康的影响
  • 批准号:
    10756039
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
  • 批准号:
    22KJ2600
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Differential impacts of water insecurity on diet and body composition throughout the life course
水不安全对整个生命过程中饮食和身体成分的不同影响
  • 批准号:
    10749236
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
Oral Feeding Difficulty in Large for Gestational Age Infants: Defining Interrelationships between Body Composition, Oral Feeding Ability, and Appetite-Regulating Hormones
大胎龄婴儿的经口喂养困难:定义身体成分、经口喂养能力和食欲调节激素之间的相互关系
  • 批准号:
    10734263
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
Staging the host in Cancer: AI-based automated comprehensive body composition assessment for Precision Medicine
对癌症宿主进行分期:基于人工智能的自动化综合身体成分评估,用于精准医学
  • 批准号:
    478392
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
    Operating Grants
Effects of bimagrumab on body composition, insulin sensitivity, and bone in adults with obesity
bimagrumab 对肥胖成人的身体成分、胰岛素敏感性和骨骼的影响
  • 批准号:
    10716254
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
Relating phthalate and metals exposure during pregnancy and perimenopause to bone health and body composition in midlife
怀孕和围绝经期期间邻苯二甲酸盐和金属暴露与中年骨骼健康和身体成分的关系
  • 批准号:
    10746972
  • 财政年份:
    2023
  • 资助金额:
    $ 0.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了